The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-19. The drugs from Pfizer and Merck join a handful of other therapies that have been shown to blunt the worst effects of the virus. But each treatment has different advantages and tends to work best for certain types of patients at different stages of the disease. Here's a look at the current COVID-19 drugs and how they are used: PILLS The prescription pills are the first COVID-19 therapies that don't require infusions or injections delivered by health professionals. The Food and Drug Administration authorized Pfizer's Paxlovid on Wednesday and Merck's molnupiravir on Thursday. Merck's drug is for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization. Pfizer's is for anyone 12 and older who likewise face the highest risks of hospitalization. Pfizer's drug is likely to become the first-choice tre
Centre on Thursday in an advisory cautioned states to observe all precautions and don't let the guard down in view of the rise in Omicron variant cases
WHO Director-General Tedros Adhanom Ghebreyesus said the priority must be to reduce deaths and help all countries meet minimum vaccination targets
The UN agency's experts regularly meet drugmakers to discuss the best composition of COVID-19 vaccines as the industry looks at whether shots need to be tweaked to tackle the coronavirus.
Meanwhile, Haryana decides to allow only fully vaccinated people at public places; Delhi bans gatherings for Christmas, New Year celebrations
Omicron has been detected in at least 38 of the WHO European region's 53 members
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), has called on the world to pull together to end the Covid-19 pandemic within the next year.
Business Standard brings you the top headlines at this hour.
Says Omicron is evading some immune responses; China must share more data on virus origins
WHO Chief Scientist Dr Soumya Swaminathan said India is one of the largest contributors of the global solidarity trial for Covid vaccines
However, it is unclear if this is due to the virus' ability to evade immunity, its inherent increased transmissibility or a combination of both, the WHO said in an update
As the world witnesses the new coronavirus variant Omicron, WHO on Saturday emphasized an urgent scale-up of public health and social measures to curtail its further spread.
The World Health Organization on Saturday stressed on urgent scale-up of public health and social measures to curtail its further spread
Arguing that the world "cannot defeat a pandemic in an uncoordinated way", UN Secretary-General Antonio Guterres said on Thursday.
The WHO Regional Office for Europe has urged people to exercise caution this holiday season, as the region is now coping with two highly transmissible coronavirus strains
"Omicron is spreading at a rate we have not seen with any previous variant. I need to be very clear: vaccines alone will not get any country out of this crisis," said Ghebreyesus.
Initial course of Covid-19 vaccines should remain a top priority, said WHO
The UN health agency also said that more information is needed to fully understand the clinical picture of those infected with Omicron
Patest data from the US Centers for Disease Control and Prevention (CDC) indicate that a third of the 43 cases of the super mutant strain in the country had taken the third dose.
COVAX needs a new set of rules in the long term to prevent the hoarding of vaccines by high income and vaccine-producing countries, a WHO senior advisor said